CRWE Wallstreet

_______________________________________

FREE Daily Stock Alerts From CRWEWallStreet.com

_______________________________________

Umpqua Holdings Corporation (NASDAQ:UMPQ), parent company of Umpqua Bank and Umpqua Investments, Inc., has raised $303.6 million in gross proceeds through its previously announced underwritten public offerings, by issuing 8,625,000 shares of the Company’s common stock, including 1,125,000 shares pursuant to the underwriter’s over-allotment option at a price of $11.00 per share; and 18,975,000 depository shares, including 2,475,000 depository shares pursuant to the underwriter’s over-allotment option, also at a price of $11.00 per share. The depository shares, as described below, represent interests in a series of Umpqua Holdings Corporation’s preferred stock designated as the Series B Common Stock Equivalent.

TaxMasters, Inc. (TAXS.OB), the IRS tax relief company, announced an increase in operational efficiency across the company’s operations and customer relationship management (CRM). The changes include an up to 50% improvement in customer response and case completion time, and a decrease in operational costs. These improvements are the result of a strategic review TaxMasters undertook in April, 2009, to increase productivity, improve customer service, and better address rising demand for its services.
Website: http://www.txmstr.com

Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the fourth quarter and year ended December 31, 2009. The company also highlighted recent product development activities and planned milestones and provided its 2010 financial outlook.

“In 2009 we made significant progress with our product pipeline, signed a strategic collaboration for our lead product candidate, brentuximab vedotin (SGN-35), entered into several new antibody-drug conjugate (ADC) deals and generated more than $120 million from both product and technology collaboration activities,” said Clay B. Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics.

Power 3 Medical Products Inc. (PWRM.OB), is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.
Web Site: http://www.Power3Medical.com

************Advertisement************

************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received twenty four thousand dollars from Tax Masters Inc.(TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received four thousand dollars from a third party (Marshall Curtis) for 30 days of advertisement for services for Tax Masters Inc.(TAXS.OB) which has expired. Crown Equity Holdings, Inc. has received an additional four thousand dollars from the same third party (Marshall Curtis) for an additional 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).